Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

A fungal enzyme was used to make compounds more soluble, aiding drug discovery and crop protection.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

BcFLA1 protein is crucial for root hair growth in response to low phosphate in Brassica carinata.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Activating TRPA1 reduces scarring and promotes tissue regeneration.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Nelfb is essential for dermal fat development and survival.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

A new topical treatment for hair loss is effective and safe with faster results.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.